Wild Wisdom

Product walkthrough

Wild Wisdom product walkthrough: the decision, the patient, the provider, the operator, the executive

The decision comes first. One patient is a journey. Hundreds become intelligence. This is Wild Wisdom in five chapters, with the product’s own screens: the constraint read that decides whether a conversion intervention is warranted at all, then one illustrative journey from the consultation to the executive decision record. The patient is not a real person and the twenty-room cohort is a fixed sample; the product is the one that runs today.

Published · By Wild Wisdom · Every screen and figure below is a synthetic sample

Chapter 1 · The decision

Which of three things is holding this treatment line back?

Operators start with the decision in front of them. One row per open decision, each scoped to one treatment line at one primary location, and each showing what it is waiting on. A decision that cannot yet be answered — no stated capacity ceiling, fewer than twelve complete baseline weeks — says so, rather than being given a provisional reading to keep a dashboard looking full.

Decisions · portfolio

Synthetic sample · illustrative figures

  1. RF Microneedling · Highland Park

    Measured period, day 30 of 30. Constraint read complete.

    Decision open

  2. Body contouring · second location

    Capacity ceiling not yet stated for this line. Nothing can be read until it is.

    Waiting on you

  3. Injectables · all locations

    Fewer than 12 complete baseline weeks. We will say so rather than read it early.

    Not yet answerable

A decision that cannot yet be answered says so. It is not given a provisional reading to keep a dashboard full.

The Constraint Brief examines the same three explanations against the same operating period: Demand, Conversion and Deliverable Capacity. It does not assume which one is responsible.

Sometimes the most useful finding is that a suspected constraint is not actually binding. That can stop an operator from spending against the wrong problem.

Every brief shows what the evidence supports, what it does not establish, and what would have to change for the conclusion to change.

Constraint brief · RF Microneedling · Highland Park

Synthetic sample · illustrative figures

  1. Demand

    NOT THE NEXT CONSTRAINT

    About 11.0 clinician-approved plans arrive each week and the line can deliver 10.7. Enough appropriate demand reaches this line for the decision in front of the partners. Demand is not the next constraint. Conversion governs the next dollar. If conversion improves, demand may become the next decision.

  2. Conversion

    BINDING

    Of 154 clinician-approved plans old enough to have booked, 88 did. The comparison this group set before we read anything was 80%. The gap is 22.9 points, or 4.7 bookings a week, above the materiality threshold of 1.5 completed treatments a week the COO approved.

  3. Deliverable capacity

    NOT BINDING

    No week in the last eight reached the booked-minutes threshold; the highest was 84%. There is room to deliver more — and closing the conversion gap is what would fill it.

What we checked

  • Consultations attended and clinician-approved plans, for 16 complete weeks
  • Bookings and completed treatments on the cohort that could have reached each step, not on activity in the period
  • Deliverable, booked and completed treatment minutes against a ceiling derived from the rota, the room schedule and the device log
  • The comparison rate this group set from its own other lines, and the materiality threshold approved before analysis
  • Patient-stated friction at readiness, for the cohort that did not book
  • Clinical declines, recorded separately and held out of every conversion denominator
What we know
Conversion is the binding constraint on this line for this period. About 11.0 clinician-approved plans arrive each week against 10.7 the line can deliver, and no week in the last eight reached the booked-minutes threshold, so neither demand nor deliverable capacity is what holds it back now. The loss is located between a clinician-approved plan and a booking, and outcome uncertainty is the friction most often still in the way for the patients who did not book.
What this does not tell you
Whether the intervention caused the difference between the two groups. Whether the three proposed locations would perform differently, which was not assessed. Anything about contribution or payback: the direct cost per completed treatment was not supplied, so no margin, ROI or payback figure appears anywhere in this record.
What would change our mind
If clinician-approved plans fell below what the line can deliver, demand would become the binding constraint and this conversion reading would be set aside. If booked minutes were sustained at Wild Wisdom's standing booked-minutes threshold, deliverable capacity would become binding and the rollout question would change shape. We re-read every period, and say so when it moves.

Recommended next step

Continue Outcome Confidence at the recommendation step on this line, and re-read the constraint at eight complete weeks.

A test was warranted here only because conversion is the binding constraint and the friction patients named has a response the clinician has already approved. Had capacity or demand been binding, the honest output would have been a decision and no test.

A test follows only where the read warrants one. Where demand or deliverable capacity binds, the output is a decision and no intervention: nothing is switched on, and the investigation has still answered the question it was bought to answer. Where too few eligible consultations or too short a window cannot separate the candidates, the output is insufficient evidence, stated as such.

Chapter 2 · The patient

Where conversion binds: a private room for one decision, read on a phone.

How can education support a decision without sales pressure?

Before a consultation, education can help a patient describe their concern and prepare questions. It should not select a treatment for them. After the consultation, the explanation should reflect the treating clinician’s recommendation, including its reasoning and relevant limitations.

Wild Wisdom’s documented patient journey includes selected Decision Stories and the clinician’s own recommendation, shown in the provider chapter. Its purpose is to make the decision easier to understand, while leaving “more information,” “not now” and “not for me” as legitimate responses.

Confirm which educational material exists for the proposed treatment line and who has reviewed it. One demonstration does not establish coverage of every procedure. Assess whether patients understand the choices and feel able to decline; conversion is not the only measure of a useful decision process.

Before the consultation, the patient opens a link to their Decision Room. It asks three things and recommends nothing: what they hope for, what is making the decision hard (one main reason and sometimes a second, from a fixed set of eight), and how confident they feel about deciding, from 1 to 7. Then, where the engagement has switched it on, a two-minute Decision Story chosen for the concern they named, with a quick check afterwards.

After the consultation the room shows what the provider recorded, and nothing about treatment appears until the provider has written it down. Where enabled, Outcome Confidence shows three relevant treatment journeys over time with their variation left in, and asks how clear the road ahead feels before and after. Then the same confidence question as at the start, what is still in the way, one flexible appointment if six conditions hold, and a decision.

Wild Wisdom

Decision Room

  1. You
  2. Understanding
  3. Your provider
  4. Where you stand
  5. Your decision
  6. Your journey

Before your consultation

Let us start with what you are hoping for.

There are no wrong answers here. This is so your provider can meet you where you actually are, rather than guessing.

Which of these is closest?

Prepared for a consultation at Calder Aesthetics Group.

Synthetic demonstration. Nothing here is about a real person, and nothing here is medical advice.

Before the consultation · product interface · synthetic data

Wild Wisdom

Decision Room

  1. You
  2. Understanding
  3. Your provider
  4. Where you stand
  5. Your decision
  6. Your journey

A short story, before your consultation

Why your skin concern and your treatment are not the same thing.

1 of 6ToneTexture

Start with what you see

Two things can bother you at once.

  • Uneven tone, or darker areas.
  • Texture, or roughness you can feel.

They often show up together. But they may not come from the same process, and they may not respond to the same kind of treatment.

Prepared for a consultation at Calder Aesthetics Group.

Synthetic demonstration. Nothing here is about a real person, and nothing here is medical advice.

Decision Story, scene 1 of 6 · product interface · synthetic data

Wild Wisdom

Decision Room

  1. You
  2. Understanding
  3. Your provider
  4. Where you stand
  5. Your decision
  6. Your journey

Before you look

How sure are you that you understand what a realistic treatment journey could look like?

What the journey can look like

Three journeys that resemble yours.

  • Journey one3 sessions

    Texture changed first; tone followed over the series.

  • Journey two4 sessions

    Partial change at eight weeks. The provider extended the series.

  • Journey three2 sessions

    Stopped early by choice; the record shows why.

Synthetic journeys, for demonstration. In the product each one is a clinician-reviewed record with its variation intact, and “Why am I seeing this?” explains the match.

Prepared for a consultation at Calder Aesthetics Group.

Synthetic demonstration. Nothing here is about a real person, and nothing here is medical advice.

Outcome Confidence · product interface · synthetic data

How do you measure patient education and decision confidence?

Measure educational exposure, understanding and treatment follow-through separately. Record which material was shown, whether it was completed, what the patient reported understanding, and what happened at later stages. A booking alone does not prove comprehension; a confident answer does not establish clinical suitability.

Wild Wisdom’s documented workflow includes a short understanding check and patient-reported confidence questions. These are patient responses, not an algorithmic suitability score. The public material does not establish that the questions are validated clinical instruments.

For an engagement, define who was eligible to see each module, account for missing responses and compare like observation windows. Keep changes in self-reported understanding separate from changes in booking and completed treatment. Report observed differences with their limitations rather than assuming the education caused the difference.

What can treatment journeys explain beyond before-and-after photos?

A before-and-after image shows selected moments. A structured treatment journey can add context: sessions, timing, recovery, variation, changes to the plan and reasons someone chose not to continue. The two formats can complement each other.

Wild Wisdom’s Outcome Confidence demonstration, above, shows illustrative journeys over time. The examples are synthetic. They are not patient results, a prediction of an individual outcome or proof that similar patients will respond similarly.

For a real example, an evaluator should be able to identify its source, permission for use, clinical review and why it is relevant. Those details should accompany the example, including uncertainty and variation. When appropriate evidence is unavailable, the clinic should explain that limitation rather than imply a personalised forecast.

Recorded, in order
Intent · concern · friction · confidence before · story shown and completed · comprehension · recommendation seen · Outcome Confidence before and after · confidence after · readiness · Flex offered, accepted or declined · decision
Never shown
A treatment menu, a price list, a predicted result, a confidence score, anything the clinician did not record

Chapter 3 · The provider

What I recommend. Why. What I would not recommend. Why not.

The clinician’s consultation page shows what the patient said, in the patient’s words, and one form. The recommendation is written by the clinician, attributed to them, submitted once, and from then on part of the record. The patient sees it as Clinical Sincerity: the recommendation, the reason, what the clinician would not do, and why not.

The clinician determines clinical appropriateness. Wild Wisdom shows the recommendation; it does not write it, score it or change it. Clinicians can also review the outcome evidence patients are shown and record real, consented journeys into the library under visible relevance rules.

Wild Wisdom

Decision Room

  1. You
  2. Understanding
  3. Your provider
  4. Where you stand
  5. Your decision
  6. Your journey

What your provider recorded

Your provider recommends RF Microneedling.

These are your provider’s own words, recorded after your consultation. Wild Wisdom shows them to you; it did not write them and does not make recommendations.

Why

What I saw is mostly surface texture with some sun-related tone change on top. RF microneedling works below the surface and asks the skin to rebuild, which addresses both together.

What they would not recommend for you, and why not

Not light-based treatment

Light-based treatment would help the spots but would do very little for the texture you are most bothered by.

Your provider at Calder Aesthetics Group

Prepared for a consultation at Calder Aesthetics Group.

Synthetic demonstration. Nothing here is about a real person, and nothing here is medical advice.

Clinical Sincerity, as the patient sees it · product interface · synthetic data
The provider sees first
Hoping for · concern · main friction · confidence before · whether the story was read · the quick-check answer
The provider writes
Recommended treatment and why · not-recommended treatment and why not
The record keeps
Who recorded it, when, and what the room knew at the time

Chapter 4 · The operator

That was one patient. Now the operator sees the cohort.

Every room is an append-only, signed record: who did what, when, and what was triggered in response. Read across a cohort, the operator console shows conversion anatomy (where people fall out, each step read on the cohort old enough to have reached it), friction anatomy (what the people who did not book said was still in the way), intervention exposure and what followed, booked and completed minutes against a stated or derived ceiling, and what the decision in front of the clinic still commits in cash it can avoid.

Each reading names a different decision. The reasoning is set out in why medspa patients don’t book after the consultation.

Conversion anatomy — where people fall out

Synthetic sample · illustrative figures

  1. Clinician-approved plans, old enough to have booked154
  2. Reached a booking88
  3. Bookings old enough to have completed66
  4. Treatment completed58

Where it lost, and what that cohort told us

  1. Approved, did not reach a booking66
  2. Opened a Decision Room41
  3. Answered readiness41

RF Microneedling · Highland Park · sixteen complete weeks. Each step is read on the cohort old enough to have reached it, not on activity in the period, so a plan approved last week is not counted as a plan that failed to book. Clinical declines are recorded separately and never appear in a conversion denominator.

Investigation · RF Microneedling · Highland Park

Synthetic sample · illustrative figures

Binding constraint

Conversion

Approved-plan volume currently exceeds deliverable treatment capacity: about 11.0 clinician-approved plans arrive each week against 10.7 the line can deliver. Conversion is the material unresolved gap, so conversion is the constraint that should govern the next decision. No week in the last eight reached the booked-minutes threshold, so deliverable capacity is not binding either. The loss sits between a clinician-approved plan and a booking.

Where the loss sits

Approved plan → Booking

66 of 154 clinician-approved plans did not reach a booking: 57% against a 80% comparison this group set from its own other device-led lines. 23 points, or 4.7 bookings a week. Booked → completed held at 88%.

Patient-stated friction, inside conversion

Outcome uncertainty

Named at readiness by 18 of the 41 Decision Rooms opened among the 66 approved plans that did not book. Same cohort as the loss: these are the people who did not book, saying what was still in the way.

What closing the gap reaches

7.7 a week

At the 80% comparison rate, holding the observed 88% booked → completed rate. The original business case assumed 9 a week. Closing the conversion gap is the right next move and it does not, on its own, deliver the business case.

Deliverable capacity · not binding

84% peak week

Read against Wild Wisdom's standing capacity threshold over the last 8 weeks, reached in none of them. Utilisation 49% across the baseline. There is room to deliver more, and closing the conversion gap is what would fill it.

What the decision commits

$446,700

The uncommitted three-location rollout commitment, first twelve months: 3 locations at $148,900 each. Every line is avoidable cash at the date of this record: nothing is leased, ordered, offered or contracted. Sunk equipment cost, theoretical utilisation and the gross value of unbooked plans are not in it, because none of them is money a decision can still avoid.

Observational. Every figure is a count of what the Decision Graph recorded; no claim of causation is made, and no significance is computed.

How do you measure treatment continuation beyond rebooking?

A booked next appointment is not a completed treatment series. To evaluate continuation, specify the clinician-approved plan, the observation window and which next sessions were due during that window.

Keep completed, overdue, not yet due, patient-paused and clinically changed or stopped plans distinct. A patient who is not yet due should not be counted as a dropout. A clinical decision to stop should not be treated as a sales failure. If the patient has not explained a non-return, its reason remains unknown.

The Wild Wisdom demonstration shows follow-through from initial intent through treatment and continuation, as the continuation reading above. The states listed here are the measurement criteria a clinic should agree for evaluation, not a claim that every state is already automated in the product.

The current screens illustrate the workflow. Establishing whether it improves series completion requires a real cohort, recorded missingness and enough follow-up to observe the agreed next steps.

Chapter 5 · The executive

One treatment. One primary location. One consequential decision.

A scoped investigation runs against a reconciled baseline of at least twelve complete weeks from the clinic’s own records. Where a test is warranted and two variants are compared, the assignment mechanism is recorded before anything is shown and rendered as what it actually is — fixed, alternating or randomised — never described generically. The sample below ran randomised, from a seed sealed in advance. Six integrity checks run over every room: a module shown that the variant did not permit, a permitted module never triggered, an event carrying another engagement’s reference, a second assignment, Flex considered before a recommendation, a room without a sealed enrolment.

At the close the executive is handed a decision record, not a report: the constraint and the constraints ruled out, the reasoning, the evidence and its provenance, what the investigation does not settle, what would change the conclusion, the retest trigger, and one decision — continue, change or stop. Sample sizes come first, differences are described rather than tested, no variant is ranked above another, and no claim of causation is made. The decision is still stated.

Wild Wisdom · Executive decision record

RF Microneedling, Highland Park

Calder Aesthetics Group · one treatment line · sixteen complete weeks, then thirty measured days

Sealed · append-only · 1 of 12

Wild Wisdom recommendation

CHANGE

Wild Wisdom recommends moving the rollout from a three-location approval to a staged approval, and holding the current three-location commitment this cycle pending the eight-week reread. The operating model being replicated has an unresolved constraint where it already runs, so this evidence does not justify approving the rollout as presented. Wild Wisdom assessed Highland Park only; the three proposed markets were not assessed and nothing here says anything about them.

  • CONTINUEOutcome Confidence at the recommendation step, on this line at Highland Park
  • CHANGEthe rollout from a three-location approval to a staged approval, gated on this line reaching the pre-agreed booking rate and on its capacity ceiling being raised
  • STOPthe current three-location rollout commitment this cycle — devices, fit-outs and hires — pending the eight-week reread

Leadership decision Not recorded in this sample. Leadership’s decision is recorded separately from Wild Wisdom’s recommendation.

Binding constraint

Conversion

Approved-plan volume currently exceeds deliverable treatment capacity: about 11.0 clinician-approved plans arrive each week against 10.7 the line can deliver. Conversion is the material unresolved gap, so conversion is the constraint that should govern the next decision. No week in the last eight reached the booked-minutes threshold, so deliverable capacity is not binding either. The loss sits between a clinician-approved plan and a booking.

Where the loss sits

Approved plan → Booking

66 of 154 clinician-approved plans did not reach a booking: 57% against a 80% comparison this group set from its own other device-led lines. 23 points, or 4.7 bookings a week. Booked → completed held at 88%.

Patient-stated friction, inside conversion

Outcome uncertainty

  • Outcome uncertainty18
  • Affordability11
  • Downtime7
  • Treatment ambiguity5

Deliverable capacity · not binding

84% peak week

Read against Wild Wisdom's standing capacity threshold over the last 8 weeks, reached in none of them. Utilisation 49% across the baseline. There is room to deliver more, and closing the conversion gap is what would fill it.

What closing the gap reaches

7.7 a week

At the 80% comparison rate, holding the observed 88% booked → completed rate. The original business case assumed 9 a week. Closing the conversion gap is the right next move and it does not, on its own, deliver the business case.

What we know

Conversion is the binding constraint on this line for this period. About 11.0 clinician-approved plans arrive each week against 10.7 the line can deliver, and no week in the last eight reached the booked-minutes threshold, so neither demand nor deliverable capacity is what holds it back now. The loss is located between a clinician-approved plan and a booking, and outcome uncertainty is the friction most often still in the way for the patients who did not book.

What this does not tell us

Whether the intervention caused the difference between the two groups. Whether the three proposed locations would perform differently, which was not assessed. Anything about contribution or payback: the direct cost per completed treatment was not supplied, so no margin, ROI or payback figure appears anywhere in this record.

What would change our mind

If clinician-approved plans fell below what the line can deliver, demand would become the binding constraint and this conversion reading would be set aside. If booked minutes were sustained at Wild Wisdom's standing booked-minutes threshold, deliverable capacity would become binding and the rollout question would change shape. We re-read every period, and say so when it moves.

What we tested, because the read warranted it

Does Outcome Confidence at the recommendation step change the share of clinician-approved plans that reach a booking?

Control · n = 23
57%
reached a booking · 13 of 23
Outcome Confidence · n = 24
71%
reached a booking · 17 of 24

Assignment mechanism: RANDOMISED, from a recorded seed sealed before any plan was assigned. Exposure delivered to 21 of 24, 88%, against a floor agreed at 80% beforehand. Observational: the 14.3-point difference is described, not tested. Bookings made inside the window need thirty-five days to reach a completed treatment, so their completion is outside this measurement and no revenue is claimed.

Next step

Continue Outcome Confidence at the recommendation step on this line, and re-read the constraint at eight complete weeks.

A test was warranted here only because conversion is the binding constraint and the friction patients named has a response the clinician has already approved. Had capacity or demand been binding, the honest output would have been a decision and no test.

Retest trigger

Re-read at eight complete weeks. Sooner if clinician-approved plans fall below what the line can deliver, which would make demand binding and set this reading aside.

What the decision commits

$446,700

The uncommitted three-location rollout commitment, first twelve months: 3 locations at $148,900 each. Every line is avoidable cash at the date of this record: nothing is leased, ordered, offered or contracted. Sunk equipment cost, theoretical utilisation and the gross value of unbooked plans are not in it, because none of them is money a decision can still avoid.

Observational. Associations are reported and no claim of causation is made. The decision, the constraint and the trigger are stated. Read at one location. Plano, Fort Worth and Austin were not assessed.

Synthetic sample · illustrative figures

Experiment
Does Outcome Confidence at the recommendation step change the share of clinician-approved plans that reach a booking?
Measured step
approved → booked
Control
n = 23 · reached a booking 13 · 57%
Outcome Confidence
n = 24 · reached a booking 17 · 71%
Design
Assignment mechanism: RANDOMISED, from a recorded seed sealed before any plan was assigned. Exposure delivered to 21 of 24, 88%, against a floor agreed at 80% beforehand. Observational: the 14.3-point difference is described, not tested. Bookings made inside the window need thirty-five days to reach a completed treatment, so their completion is outside this measurement and no revenue is claimed.

Synthetic sample · illustrative figures

Close the decision · continue, change or stop

CHANGE

Wild Wisdom recommends moving the rollout from a three-location approval to a staged approval, and holding the current three-location commitment this cycle pending the eight-week reread. The operating model being replicated has an unresolved constraint where it already runs, so this evidence does not justify approving the rollout as presented. Wild Wisdom assessed Highland Park only; the three proposed markets were not assessed and nothing here says anything about them.

Retest trigger
Re-read at eight complete weeks. Sooner if clinician-approved plans fall below what the line can deliver, which would make demand binding and set this reading aside.
Recorded as
An append-only event, sealed against the one before it, carrying who closed it, when, and the evidence the reading rested on. A later reversal is a new event that says what it reverses; nothing is edited or deleted.

Synthetic sample · illustrative figures

Evaluating Wild Wisdom?

The buyer’s questions, who it is for, what an engagement needs, what exists today and what it deliberately does not do, are answered on medspa consultation conversion software. The category is defined in what is conversion intelligence for medical aesthetics.

What is breaking in your patient journey?